Cargando…

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

Oestrogen receptor alpha (ERα) is an oestrogen-activated transcription factor, which regulates proliferation and differentiation of mammary epithelial cells by activating or repressing gene expression. ERα is a critical prognostic indicator and a therapeutic target for breast cancer. Patients with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat-Nakshatri, P, Campbell, R A, Patel, N M, Newton, T R, King, A J, Marshall, M S, Ali, S, Nakshatri, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410160/ https://www.ncbi.nlm.nih.gov/pubmed/14970864 http://dx.doi.org/10.1038/sj.bjc.6601541

Ejemplares similares

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003)

Expression of oestrogen receptor beta (ERβ1) protein in human breast cancer biopsies
por: Saunders, P T K, et al.
Publicado: (2002)

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
por: Journe, F, et al.
Publicado: (2004)

Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
por: Murphy, L C, et al.
Publicado: (2002)

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
por: Hardt, P D, et al.
Publicado: (2004)

Wild-type oestrogen receptor beta (ERβ1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
por: O'Neill, P A, et al.
Publicado: (2004)

Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure
por: Tonetti, D A, et al.
Publicado: (2003)

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
por: Müller, H M, et al.
Publicado: (2003)

Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002)

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
por: Altura, R A, et al.
Publicado: (2003)

The embedded tumour: host physiology is important for the evaluation of tumour growth
por: van Leeuwen, I M M, et al.
Publicado: (2003)

Prognostic impact of chromosomal aberrations in Ewing tumours
por: Hattinger, C M, et al.
Publicado: (2002)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

DNA topoisomerase I and II expression in drug resistantgerm cell tumours
por: Berney, D M, et al.
Publicado: (2002)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells
por: Lewis, M P, et al.
Publicado: (2004)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma
por: Lemaire, F, et al.
Publicado: (2004)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003)

RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma
por: Shyu, R-Y, et al.
Publicado: (2003)

Additive interaction of gefitinib (‘Iressa’, ZD1839) and ionising radiation in human tumour cells in vitro
por: Giocanti, N, et al.
Publicado: (2004)

Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation
por: McKeown, S R, et al.
Publicado: (2003)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?
por: Handgretinger, R, et al.
Publicado: (2003)

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
por: Mamot, C, et al.
Publicado: (2003)

Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
por: Fiegl, M, et al.
Publicado: (2004)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
por: Bernsen, M R, et al.
Publicado: (2003)

Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours
por: Zurita, A J, et al.
Publicado: (2003)

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma
por: Miyazaki, T, et al.
Publicado: (2003)

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development
por: Zuidervaart, W, et al.
Publicado: (2003)

DNA replication licensing and cell cycle kinetics of oligodendroglial tumours
por: Wharton, S B, et al.
Publicado: (2004)

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
por: Vicent, S, et al.
Publicado: (2004)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
por: Dirix, L Y, et al.
Publicado: (2002)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Identifying pre-post chemotherapy differences in gene expression in breast tumours: a statistical method appropriate for this aim
por: Korn, E L, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_eqspj95b5j6g6jsqtbgarc1ivs